Quick Answer
Bone Biologics Corp reported Cash And Cash Equivalents At Carrying Value of $6.68 million for the year ending 2021.
- Bone Biologics Corp showed an increase of +27,547.0% in Cash And Cash Equivalents At Carrying Value from 2019 to 2021.
- This data is from Bone Biologics Corp's annual report (Form 10-K), filed with the SEC on March 15, 2022.
- XBRL data for this metric is available from 2011 to 2021 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2021: $6.68 million | Fiscal year 2019: $24.1 thousand | Fiscal year 2018: $955.4 thousand | Fiscal year 2017: $690.3 thousand | Fiscal year 2017: $1.62 million | Fiscal year 2017: $783.0 thousand | Fiscal year 2017: $1.61 million | Fiscal year 2016: $620.4 thousand | Fiscal year 2016: $688.2 thousand | Fiscal year 2016: $2.19 million | Fiscal year 2016: $4.22 million | Fiscal year 2015: $1.12 million | Fiscal year 2014: $2.66 million | Fiscal year 2013: $1.5 thousand | Fiscal year 2013: $380.00 | Fiscal year 2012: $2.4 thousand | Fiscal year 2012: $500.00 | Fiscal year 2011: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: